# BridgeBio Pharma, Inc.: Form SC 13D/A, filed Dec 7, 2018

- Company: [BridgeBio Pharma, Inc.](/companies/bbio.md) (CIK 1743881)
- Form: SC 13D/A
- Filed: 2018-12-07
- Accepted by EDGAR: Dec 6, 2018, 20:50 ET
- Period: not reported
- Accession: 0001193125-18-344046
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1743881/000119312518344046/d668976dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1743881/000119312518344046/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1743881/000119312518344046/d668976dsc13da.htm

Filed Dec 7, 2018.
Source: SEC EDGAR, the filing index for accession 0001193125-18-344046. Last ingested by Listed: Nov 12, 2026, 17:56 ET. No prices; not investment advice.
